Insights Now

著者: Dr. David Kelly J.P. Morgan Asset Management
  • サマリー

  • Listen to the latest insights from Dr. David Kelly, Chief Global Strategist at J.P. Morgan Asset Management, where he sits down with a variety of thought leaders for a conversational breakdown of big ideas, future trends, emerging topics and their investment implications to help inform building stronger investment plans for the long-term.
    Copyright 2024 All rights reserved.
    続きを読む 一部表示

あらすじ・解説

Listen to the latest insights from Dr. David Kelly, Chief Global Strategist at J.P. Morgan Asset Management, where he sits down with a variety of thought leaders for a conversational breakdown of big ideas, future trends, emerging topics and their investment implications to help inform building stronger investment plans for the long-term.
Copyright 2024 All rights reserved.
エピソード
  • Asset allocation in the year ahead
    2024/11/21

    Watch the video version on YouTube.

    As we usher in a new year, the investment landscape is almost certainly set to change. That’s why in our twelfth season of Insights Now titled, “Preparing for the path forward,” Dr. David Kelly will sit down with portfolio managers and strategists from across J.P. Morgan to discuss their key takeaways from 2024, and what they expect from the economy and markets in 2025. With the new year just around the corner, tune in to hear what opportunities we are most excited about, and what risks we are most mindful of, heading into the new year. With the U.S. election in the rear-view mirror and the Federal Reserve finally easing policy, the forces driving financial markets in 2025 could differ greatly from 2024. Policy uncertainty should step in for election uncertainty, and the monetary policy debate will center around how quickly the Fed will cut, not when it will begin cutting. Still, with the U.S. economy displaying impressive resilience and structural tailwinds supporting prospects abroad, there remains a wide menu of attractive opportunities for investors to consider across global stocks and bonds, and plenty of ways to diversify. That said, markets can move quickly. Investors striving for alpha should be active in portfolios and allocate to their highest conviction ideas instead of sitting passively on the sidelines. To share some of his highest conviction ideas for the year ahead, Dr. David Kelly is joined by Phil Camporeale, Portfolio Manager in our Multi Asset Solutions group here at J.P. Morgan Asset Management.

    Resources:

    For more resources visit our website.

    Subscribe to the Notes on the Week Ahead podcast for more insights from Dr. David Kelly: Apple Podcasts | Spotify

    続きを読む 一部表示
    17 分
  • Alternative Realities: Powering portfolios with alternatives
    2024/11/14

    Watch the video version on YouTube.

    In this episode, Dr. David Kelly is joined by Ash Williams, Vice Chair of J.P. Morgan Asset Management. Ash served as Chief Investment Officer and Executive Director of the Florida State Board of Administration, where he oversaw $250 billion in assets. He has extensive experience as an institutional investor in both public and private markets. Throughout their conversation, they cover a range of topics surrounding the importance of alternatives in a portfolio and the best approach to constructing a portfolio with alternatives.

    Timestamps:

    • Introduction (00:00:00)
    • Risk and return within alternatives (01:27)
    • Allocating capital toward alternatives (04:37)
    • Process of picking specific alternatives (06:30)
    • Institutional vs. individual portfolio allocations to alternatives (13:01)
    • Importance of manager selection (15:40)
    • Opportunities in alternatives today (17:06)

    Resources:

    For more resources on Alternatives, visit our Guide to Alternatives and Principles of Alternatives Investing

    Listen to the audio version of the Alternative Realities podcast: Apple Podcasts | Spotify

    続きを読む 一部表示
    20 分
  • Alternative Realities: Investing in the future of healthcare
    2024/10/31

    Watch the video version on YouTube.

    On previous episodes, we’ve discussed the muted return outlook for a traditional 60/40 portfolio, and the return enhancing potential of Private Equity and Venture Capital. As companies wait longer to IPO, investors are turning to private markets for access to the fastest growing part of a business’s lifecycle. In this episode, we’re going to explore the opportunities in private healthcare and biotechnology. Dr. David Kelly is joined by Gaurav Gupta, Managing Partner of Life Science Private Capital within J.P. Morgan Private Capital. He is a neurosurgeon turned investor, and we’re so excited to have him here to discuss the trends he’s seeing in the market.

    Timestamps:

    • Typical healthcare investments (1:01)
    • Investing in private healthcare vs. public healthcare (5:42)
    • Private equity exits and valuations in healthcare (9:13)
    • AI and drug development in healthcare (10:56)
    • Regulatory changes within healthcare investment (16:06)
    • Best opportunities in healthcare investment (18:33)

    Resources:

    • For more resources on Alternatives, visit our Guide to Alternatives and Principles of Alternatives Investing
    • Listen to the audio version of the Alternative Realities podcast: Apple Podcasts | Spotify
    続きを読む 一部表示
    25 分

Insights Nowに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。